Curcumin, the active compound in turmeric, has documented anti-inflammatory mechanisms including NF-kB pathway inhibition and TNF-alpha and IL-6 suppression, both of which are directly implicated in HS disease activity. There are no completed HS-specific randomised controlled trials for curcumin. The evidence is mechanistic and extrapolated from other inflammatory conditions. Standard culinary turmeric and most cheap curcumin capsules deliver negligible absorbed curcumin, making form the determining factor in whether this ingredient does anything.
What curcumin actually does in the body
Curcumin is the principal bioactive polyphenol in turmeric. Three mechanisms are directly relevant to HS.
NF-kB inhibition. NF-kB is one of the primary inflammatory signalling pathways in HS. It drives the production of pro-inflammatory cytokines responsible for recurring nodules, abscesses, and tissue damage. Curcumin is one of the most studied natural inhibitors of this pathway.
TNF-alpha and IL-6 suppression. Both cytokines are elevated in HS patients and directly contribute to disease severity. Adalimumab (Humira), the first biologic approved for HS, works by blocking TNF. Curcumin suppresses TNF-alpha through a different mechanism and at a far more modest level, but the shared target is mechanistically relevant.
Oxidative stress reduction. HS creates significant oxidative stress in affected tissue. Curcumin has documented antioxidant effects that reduce oxidative markers in chronic inflammatory conditions.
These are real mechanisms with published evidence. The absence of an HS-specific RCT does not make them irrelevant. But it does mean the evidence base is extrapolated, not direct.
Why there's no HS-specific clinical trial for curcumin
Curcumin is a natural compound that cannot be patented in standard forms. The financial incentive to run a large HS-specific RCT is limited.
What this means in practice: curcumin in HS should be framed as biologically plausible, with documented anti-inflammatory mechanisms relevant to the condition, but unproven at the HS-specific clinical level. That is the accurate framing. And it is the kind of honesty that builds credibility.
The problem with turmeric in food and standard capsules
Standard curcumin, whether from culinary turmeric or cheap capsules, has a bioavailability of less than 1%. The vast majority passes through the digestive system before the body can absorb and use it.
This is why many people try "turmeric," notice nothing, and conclude that curcumin doesn't work. The problem is almost never the compound. The problem is the form.
How delivery systems change the absorption picture
Curcumin with piperine (black pepper extract): Piperine inhibits certain metabolic enzymes (CYP3A4 and P-glycoprotein), increasing curcumin absorption approximately 20-fold. However, the same mechanism increases the absorption of many prescription medications. For HS patients on multiple prescriptions, piperine-curcumin combinations create a potential drug interaction concern worth flagging to your prescriber.
Curcumin phytosome: Curcumin is bound to phospholipids, the same molecules that make up cell membranes. This allows curcumin to pass through the intestinal wall far more efficiently. Multiple studies have shown 20-29x bioavailability improvement over standard curcumin powder. It does not carry the medication interaction concerns associated with piperine.
Liposomal curcumin: Encapsulated in lipid spheres. Effective but less widely studied than the phytosome form.
Who may benefit and realistic expectations
The people most likely to see any benefit are those with Hurley Stage 1-2 HS, using curcumin as one component of a broader approach. Curcumin should not be framed as a replacement for prescribed treatment at any stage.
HS Daily includes curcumin phytosome at 300mg (10% curcuminoids). The original formulation intended 1,000mg, but this was reduced to 300mg due to taste constraints in the powder sachet format. This is a formulation compromise, not an evidence-based optimum. The phytosome form's 20-29x bioavailability advantage partially compensates, but 300mg phytosome is a modest dose and should not be treated as a clinically therapeutic amount. It contributes to the anti-inflammatory rationale of the formula; it is not a primary driver of outcomes.
What to discuss with your dermatologist
If you are on multiple prescription medications for HS, tell your dermatologist or pharmacist that you are considering curcumin supplementation, particularly if the product contains piperine.
Curcumin phytosome without piperine does not carry this interaction concern.
For more on the evidence base behind the other supplement ingredients researched in HS contexts, see our guide to what supplements actually help hidradenitis suppurativa (add URL when Post #10 publishes)
Get your free HS Nutrition Guide
What the research actually says about nutrition and HS — ingredients, doses, forms, and what the evidence does and doesn't support.
Frequently asked questions
Does turmeric in cooking help HS?
Not meaningfully. Standard dietary turmeric has less than 1% bioavailability for curcumin. The amount reaching circulation from cooking with turmeric, even with black pepper added, is well below the levels used in anti-inflammatory research.
Is curcumin safe to take with HS medications?
Curcumin phytosome (without piperine) is generally well tolerated alongside the biologics, antibiotics, and hormonal therapies used in HS. Curcumin combined with piperine has potential drug interactions. If your HS regimen includes prescription medication, check with your prescriber before using a piperine-containing curcumin supplement.
How long does curcumin take to show any effect?
In other inflammatory conditions, anti-inflammatory effects on biomarkers build over weeks of consistent supplementation. An evaluation window of 8-12 weeks of daily, well-absorbed curcumin is a reasonable minimum.
Why isn't curcumin in more HS clinical guidelines?
The absence of completed HS-specific randomised controlled trials means clinical guidelines cannot formally recommend curcumin for HS. This reflects the evidence gap, not the plausibility of the mechanism.
This article is for educational purposes only. It is not a substitute for medical advice. If you have hidradenitis suppurativa, work with a board-certified dermatologist to build a treatment plan.
References
- Curcumin NF-kB inhibition and cytokine suppression. https://pubmed.ncbi.nlm.nih.gov/36911003/
- Curcumin phytosome bioavailability 20-29x. https://pubmed.ncbi.nlm.nih.gov/21413691/
Published by HS Daily.
